Evidence map›Paper›PMID 15745947›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2005

Glutamate receptor trafficking: endoplasmic reticulum quality control involves ligand binding and receptor function.

Stephanie J Mah, Elizabeth Cornell, Nicholas A Mitchell, Mark W Fleck

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Protein quality control ofFrontiers in cellular neuroscience · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in molecular neuroscience · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Stephanie J MahCenter for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208, USA.
Elizabeth Cornell
Nicholas A Mitchell
Mark W Fleck
Albany Medical Center Hospital · US

Funding

AGONIST GATING OF NON-DESENSITIZING AMPA RECEPTORSR01NS040347 · NINDS · ALBANY MEDICAL COLLEGE · PI FLECK, MARK W · 2001 to 2004
$957k
NINDS NIH HHS NS40347NINDS NIH HHS R01 NS040347
6 · The paper itself

Abstract

The glutamate receptor (GluR) agonist-binding site consists of amino acid residues in the extracellular S1 and S2 domains in the N-terminal and M3-M4 loop regions, respectively. In the present study, we sought to confirm that the conserved ligand-binding residues identified in the AMPA receptor S1S2 domains also participate in ligand binding of GluR6 kainate receptors. Amino acid substitutions were made in the GluR6 parent at R523, T690, and E738 to alter their potential interactions with ligand. Mutant receptors were expressed in human embryonic kidney 293 cells, confirmed by Western blot analysis, and tested by [3H]kainate binding and patch-clamp recording. Each of the binding site mutations was sufficient to reduce [3H]kainate binding to undetectable levels and eliminate functional responses to glutamate or kainate. As with our studies of other nonfunctional mutants (Fleck et al., 2003), immunocytochemical staining and cell-surface biotinylation studies showed that the mutant receptors were retained intracellularly and did not traffic to the cell surface. Endoglycosidase-H digests and colocalization with endoplasmic reticulum (ER) markers demonstrated that the mutant receptors are immaturely glycosylated and retained in the ER. Immunoprecipitation, native PAGE, and functional studies confirmed that the GluR6-binding site mutants are capable of multimeric assembly, indicating their retention in the ER does not result from a gross protein folding error. Together, these results confirm the role of R523, T690, and E738 directly in ligand binding to GluR6 and further support our previous report that nonfunctional GluRs are retained intracellularly by a functional checkpoint in ER quality control.

Indexed as

LigandsAmino Acid SubstitutionBinding SitesBiotinylationBlotting, WesternCell LineDose-Response Relationship, DrugDose-Response Relationship, RadiationElectric StimulationEndoplasmic ReticulumGene ExpressionGluK2 Kainate ReceptorGlutamic AcidGlycosylationHumansImmunohistochemistryGluK2 Kainate Receptorglutamate receptor ionotropic, AMPA 2Glutamic AcidKainic AcidKainic Acid ReceptorsLigandsLuminescent ProteinsMannosyl-Glycoprotein Endo-beta-N-AcetylglucosaminidasePeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseReceptors, AMPATritium

Identifiers

PMID15745947
PMCPMC6726086
OpenAlexW2090929012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.